Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Johnson, D. A. W.
1978.
Management of Schizophrenia.
Scottish Medical Journal,
Vol. 23,
Issue. 3,
p.
227.
Johnson, D. A. W.
1979.
Further Observations on the Duration of Depot Neuroleptic Maintenance Therapy in Schizophrenia.
British Journal of Psychiatry,
Vol. 135,
Issue. 6,
p.
524.
Johnson, D. A. W.
1981.
Studies of Depressive Symptoms in Schizophrenia.
British Journal of Psychiatry,
Vol. 139,
Issue. 2,
p.
89.
Cheung, Hung K.
1981.
Schizophrenics Fully Remitted on Neuroleptics for 3–5 years—To Stop or Continue Drugs?.
British Journal of Psychiatry,
Vol. 138,
Issue. 6,
p.
490.
Johnson, D. A. W.
1981.
Depressions in schizophrenia: Some observations on prevalence, etiology, and treatment.
Acta Psychiatrica Scandinavica,
Vol. 63,
Issue. S291,
p.
137.
McCreadie, Robin G.
Barron, Elizabeth T.
and
Winslow, George S.
1982.
The Nithsdale Schizophrenia Survey: II. Abnormal Movements.
British Journal of Psychiatry,
Vol. 140,
Issue. 6,
p.
587.
Curson, D. A.
Barnes, T. R. E.
Bamber, R. W.
Platt, S. D.
Hirsch, S. R.
and
Duffy, J. C.
1985.
III. Relapse Postponement or Relapse Prevention? The Implications for Long-term Outcome.
British Journal of Psychiatry,
Vol. 146,
Issue. 5,
p.
474.
Johnson, D. A. W.
1985.
Clinical Psychopathology Nomenclature and Classification.
p.
589.
Knudsen, Peder
Hansen, Lars Bolvig
Højholdt, Karsten
and
Larsen, Niels‐Erik
1985.
Long‐term Depot Neuroleptic Treatment With Perphenazine Decanoate I.
Acta Psychiatrica Scandinavica,
Vol. 72,
Issue. S322,
p.
29.
Johnson, D. A. W.
1985.
Psychiatry the State of the Art.
p.
745.
Barnes, Thomas R. E.
and
Weller, Malcolm P. I.
1986.
Movement Disorders.
p.
323.
Altamura, Alfredo Carlo
Mauri, Massimo C.
Guercetti, Grazia
and
Cazzullo, Carlo L.
1987.
Fluphenazine decanoate in acute and maintenance therapy of schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 11,
Issue. 5,
p.
613.
Hardie, R J
and
Lees, A J
1988.
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 51,
Issue. 6,
p.
850.
Karki, Shyam D.
Chandra, Pradeep
Holden, J. M. C.
and
Shehata, Hany
1988.
Impact of team approach on reducing drug costs.
International Journal of Geriatric Psychiatry,
Vol. 3,
Issue. 2,
p.
89.
Lader, M.
1989.
Clinical Pharmacology of Antipsychotic Drugs.
Journal of International Medical Research,
Vol. 17,
Issue. 1,
p.
1.
Sandyk, Reuven
and
Pardeshi, Ramsing
1990.
Pyridoxine Improves Drug-Induced Parkinsonism and Psychosis in a Schizophrenic Patient.
International Journal of Neuroscience,
Vol. 52,
Issue. 3-4,
p.
225.
Johnson, D. A. W.
and
Wright, N. F.
1990.
Drug Prescribing for Schizophrenic Out-patients on Depot Injections.
British Journal of Psychiatry,
Vol. 156,
Issue. 6,
p.
827.
Boodhoo, Jean Antoine
and
Sandler, Martin
1990.
Anticholinergics: the consensus statement.
British Journal of Psychiatry,
Vol. 156,
Issue. 6,
p.
905.
Silverstone, Trevor
1990.
Clinically relevant differences between antipsychotic compounds.
Acta Psychiatrica Scandinavica,
Vol. 82,
Issue. S358,
p.
88.
Johnson, Donald
1990.
Long-Term Drug Treatment of Psychosis: Observations on some Current Issues.
International Review of Psychiatry,
Vol. 2,
Issue. 3-4,
p.
341.
eLetters
No eLetters have been published for this article.